NCT03183323

Brief Summary

ITISHOPE4HF is a randomized controlled trial of telerehabilitation in a heart failure population. The goal is to evaluate if a home-based telerehabilitation project can increase physical activity in heart failure patients. Patients will be provided telerehabilitation or advice on physical activity (standard care).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

June 8, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 12, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

3.7 years

First QC Date

May 30, 2017

Last Update Submit

April 7, 2022

Conditions

Keywords

hfpefhfrefcardiorenal syndromeexercisetelerehabilitationrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Improvement in long-term physical activity.

    Change in physical activity between intervention and control group measured throughout the study with Actigraph activity trackers from baseline to 2 years.

    2 years

Secondary Outcomes (8)

  • Changes in cardiac structure and function.

    2 years.

  • Change in physical fitness.

    2 years

  • Effects on renal function.

    2 years.

  • Long-term effects on cardiovascular risk factors.

    2 years.

  • Effects on endothelial function.

    2 years.

  • +3 more secondary outcomes

Other Outcomes (11)

  • Differences in heart failure presentation associated with co-morbid chronic kidney disease.

    Baseline.

  • The association of cardiac fibrosis with cardiorenal syndrome

    Baseline

  • Feasibility of telerehabilitation

    6 months.

  • +8 more other outcomes

Study Arms (2)

Telerehabilitation

EXPERIMENTAL

In addition to optimal medical treatment: 3 months of twice weekly group-based telerehabilitation through a video-conferencing on a tablet platform. In addition access to instruction videos for further self-training through the same platform and throughout the whole 2-year period. Electronic devices to trace activity.

Behavioral: Telerehabilitation

Standard care

NO INTERVENTION

In addition to optimal medical treatment: Advice on physical activity. Electronic devices to trace activity.

Interventions

Activity trackers. Mio Slice is worn through the whole study. Actigraph is worn for one week, at 4 different timepoints through the study.

Also known as: Mio Slice, Actigraph
Telerehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heart failure (HFpEF or HFrEF) according to European guidelines.
  • Moderate or severe signs and symptoms of heart failure (NYHA II-III) in the 6 months prior to enrolment.
  • N-terminal pro brain natriuretic peptide (NT-proBNP) \> 300 pmol/L.
  • Stable (\> 4 weeks) medical therapy for risk factor control.
  • Capability to provide signed, informed, written consent.

You may not qualify if:

  • Attendance at a rehabilitation program in the 6 months prior to enrolment.
  • Non-heart failure causes of heart failure symptoms (significant valvular disease, coronary disease available for revascularization, uncontrolled hypertension, arrhythmia).
  • severe or very severe pulmonary disease (eg. COPD GOLD III-IV).
  • presence of conditions which might prevent patients from safely exercising at home.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Olav University Hospital

Trondheim, 7491, Norway

Location

Related Publications (2)

  • Lundgren KM, Langlo KAR, Salvesen O, Aspvik NP, Mo R, Ellingsen O, Vesterbekkmo E, Zanaboni P, Dalen H, Aksetoy IA. Exercise-Based Telerehabilitation for Heart Failure Patients Declining Outpatient Rehabilitation-A Randomized Controlled Trial. Med Sci Sports Exerc. 2025 Mar 1;57(3):449-460. doi: 10.1249/MSS.0000000000003590. Epub 2024 Nov 6.

  • Lundgren KM, Langlo KAR, Salvesen O, Zanaboni P, Cittanti E, Mo R, Ellingsen O, Dalen H, Aksetoy IA. Feasibility of telerehabilitation for heart failure patients inaccessible for outpatient rehabilitation. ESC Heart Fail. 2023 Aug;10(4):2406-2417. doi: 10.1002/ehf2.14405. Epub 2023 May 23.

MeSH Terms

Conditions

Heart Failure, SystolicHeart Failure, DiastolicRenal Insufficiency, ChronicCardio-Renal SyndromeMotor Activity

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Havard Dalen, MD, PhD

    Norwegian University of Science and Tehnology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Group assignment is not masked at performance tests. Group assignment is masked to the echo/MRI technician, and for investigators interpreting the recordings. Masking is not relevant for laboratory analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: RCT, 1:1 into telerehabilitation or standard care. Patients will be stratified by EF \>/\< 40 %, age \>/\< 60 years and by sex.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2017

First Posted

June 12, 2017

Study Start

June 8, 2017

Primary Completion

February 28, 2021

Study Completion

February 28, 2021

Last Updated

April 14, 2022

Record last verified: 2022-04

Locations